Skip to content

Clinical trials

Completed Hematologic Neoplasms trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Status: Completed Country / region: Israel Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20071
20091
20102
20131
20151
20161
20191
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
AGC Biologics S.p.A.1
European Society for Blood and Marrow Transplantation1
Gamida Cell -Teva Joint Venture Ltd.1
Gamida Cell ltd1
Janssen Research & Development, LLC1
Merck Sharp & Dohme LLC1
Mirror Biologics, Inc.1
Nucleix Ltd.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms11
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Lymphoma3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Hodgkin Disease2
Leukemia, Myeloid, Acute2
Lymphoma, Non-Hodgkin2
Myelodysplastic Syndromes2
Central Nervous System Infections1
Hematologic Diseases1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.